Abstract
Joint arthroplasty, a procedure that can relieve patients of life-altering and debilitating pain, has proven to be so successful that over 1,000,000 procedures are performed annually in the USA alone. However, a prosthetic joint infection represents a devastating complication for patients which can lead to not only revision surgery but possible permanent loss of function, amputation, and even death. Infection can present not only in the immediate postoperative period but at any point for the duration of the implant’s life.
The challenges confronting providers are numerous. Diagnostic testing has varying sensitivities and specificities depending on duration of infection meaning there is no true “gold standard” for testing. Additionally, once the diagnosis of infection is made, treatment options are limited and have high rates of morbidity and mortality.
Given the impending rise in total joint arthroplasty case volume and subsequent revision case volume due to PJI, an urgent need exists for continued work in the development of preventive, diagnostic, and therapeutic tools.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Scott CE, Bugler KE, Clement ND, MacDonald D, Howie CR, Biant LC (2012) Patient expectations of arthroplasty of the hip and knee. J Bone Joint Surg Br 94(7):974–981
Palazzo C, Jourdan C, Descamps S, Nizard R, Hamadouche M, Anract P, Boisgard S, Galvin M, Ravaud P, Poiraudeau S (2014) Determinants of satisfaction 1 year after total hip arthroplasty: the role of expectations fulfilment. BMC Musculoskelet Disord 15:53
Sloan M, Premkumar A, Sheth NP (2018) Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 100(17):1455–1460
Bozic KJ, Ries MD (2005) The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 87(8):1746–1751
Namba RS, Inacio MC, Paxton EW (2013) Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am 95(9):775–782
Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC (2009) National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 37(10):783–805
Huotari K, Peltola M, Jamsen E (2015) The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop 86(3):321–325
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J (2009) Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplast 24(6 Suppl):105–109
Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA (2014) The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplast 29(5):929–932
Kapadia BH, Banerjee S, Cherian JJ, Bozic KJ, Mont MA (2016) The economic impact of periprosthetic infections after total hip arthroplasty at a Specialized Tertiary-Care Center. J Arthroplast 31(7):1422–1426
Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ (2002) The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 23(4):183–189
de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37(5):387–397
Berend KR, Lombardi AV Jr, Morris MJ, Bergeson AG, Adams JB, Sneller MA (2013) Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 471(2):510–518
Choi HR, Beecher B, Bedair H (2013) Mortality after septic versus aseptic revision total hip arthroplasty: a matched-cohort study. J Arthroplast 28(8 Suppl):56–58
Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89(4):780–785
Tsukayama DT, Goldberg VM, Kyle R (2003) Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am 85-A(Suppl 1):S75–S80
Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 78(4):512–523
Parvizi J, Gehrke T (2014) Definition of periprosthetic joint infection. J Arthroplast 29(7):1331
McPherson EJ, Tontz W Jr, Patzakis M, Woodsome C, Holtom P, Norris L, Shufelt C (1999) Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop (Belle Mead NJ) 28(3):161–165
Li C, Renz N, Trampuz A (2018) Management of Periprosthetic Joint Infection. Hip Pelvis 30(3):138–146
Luthringer TA, Fillingham YA, Okroj K, Ward EJ, Della Valle C (2016) Periprosthetic joint infection after hip and knee arthroplasty: a review for emergency care providers. Ann Emerg Med 68(3):324–334
Cook JL, Scott RD, Long WJ (2007) Late hematogenous infections after total knee arthroplasty: experience with 3013 consecutive total knees. J Knee Surg 20(1):27–33
Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112(10):1466–1477
Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res (437):7–11
Barth E, Myrvik QM, Wagner W, Gristina AG (1989) In vitro and in vivo comparative colonization of Staphylococcus aureus and Staphylococcus epidermidis on orthopaedic implant materials. Biomaterials 10(5):325–328
Alamanda VK, Springer BD (2019) The prevention of infection: 12 modifiable risk factors. Bone Joint J 101-b(1_Supple_A):3–9
Kee JR, Mears SC, Edwards PK, Barnes CL (2017) Modifiable risk factors are common in early revision hip and knee arthroplasty. J Arthroplast 32(12):3689–3692
Namba RS, Paxton L, Fithian DC, Stone ML (2005) Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplast 20(7 Suppl 3):46–50
Smith JO, Frampton CMA, Hooper GJ, Young SW (2018) The impact of patient and surgical factors on the rate of postoperative infection after total hip arthroplasty—a New Zealand Joint Registry Study. J Arthroplast 33(6):1884–1890
Wagner ER, Kamath AF, Fruth KM, Harmsen WS, Berry DJ (2016) Effect of body mass index on complications and reoperations after total hip arthroplasty. J Bone Joint Surg Am 98(3):169–179
Cancienne JM, Werner BC, Browne JA (2017) Is there a threshold value of hemoglobin A1c that predicts risk of infection following primary total hip arthroplasty? J Arthroplast 32(9s):S236–s240
Tarabichi M, Shohat N, Kheir MM, Adelani M, Brigati D, Kearns SM, Patel P, Clohisy JC, Higuera CA, Levine BR, Schwarzkopf R, Parvizi J, Jiranek WA (2017) Determining the threshold for HbA1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study. J Arthroplasty 32(9s):S263–S267.e1
Bedard NA, DeMik DE, Owens JM, Glass NA, DeBerg J, Callaghan JJ (2019) Tobacco use and risk of wound complications and periprosthetic joint infection: a systematic review and meta-analysis of primary total joint arthroplasty procedures. J Arthroplast 34(2):385–396.e4
Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ (2012) Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 94(9):794–800
Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ (2012) Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res 470(1):130–137
Poultsides LA, Ma Y, Della Valle AG, Chiu YL, Sculco TP, Memtsoudis SG (2013) In-hospital surgical site infections after primary hip and knee arthroplasty—incidence and risk factors. J Arthroplast 28(3):385–389
Cordtz RL, Zobbe K, Hojgaard P, Kristensen LE, Overgaard S, Odgaard A, Lindegaard H, Dreyer L (2018) Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers. Ann Rheum Dis 77(2):281–288
Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, Gewurz-Singer O, Giles JT, Johnson B, Lee S, Mandl LA, Mont MA, Sculco P, Sporer S, Stryker L, Turgunbaev M, Brause B, Chen AF, Gililland J, Goodman M, Hurley-Rosenblatt A, Kirou K, Losina E, MacKenzie R, Michaud K, Mikuls T, Russell L, Sah A, Miller AS, Singh JA, Yates A (2017) 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol 69(8):1538–1551
Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, Imamura H, Masuda I, Tokita A, Ikari K (2011) Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol 21(5):469–475
Suzuki M, Nishida K, Soen S, Oda H, Inoue H, Kaneko A, Takagishi K, Tanaka T, Matsubara T, Mitsugi N, Mochida Y, Momohara S, Mori T, Suguro T (2011) Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association. J Orthop Sci 16(6):778–784
Pruzansky JS, Bronson MJ, Grelsamer RP, Strauss E, Moucha CS (2014) Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J Arthroplast 29(2):272–276
Swenson RD, Butterfield JA, Irwin TJ, Zurlo JJ, Davis CM 3rd (2018) Preoperative anemia is associated with failure of open debridement polyethylene exchange in acute and acute hematogenous prosthetic joint infection. J Arthroplast 33(6):1855–1860
Pugely AJ, Martin CT, Gao Y, Schweizer ML, Callaghan JJ (2015) The incidence of and risk factors for 30-day surgical site infections following primary and revision total joint arthroplasty. J Arthroplast 30(9 Suppl):47–50
Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL (2008) Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 59(12):1713–1720
Bedair H, Goyal N, Dietz MJ, Urish K, Hansen V, Manrique J, Hamilton W, Deirmengian G (2015) A history of treated Periprosthetic joint infection increases the risk of subsequent different site infection. Clin Orthop Relat Res 473(7):2300–2304
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD (2016) Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One 11(3):e0150866
Prosthetic Joint Infection risk calculator. https://icmphilly.com/ortho-applications/prosthetic-joint-infection-pji-risk-calculator/
Amanatullah D, Dennis D, Oltra EG, Marcelino Gomes LS, Goodman SB, Hamlin B, Hansen E, Hashemi-Nejad A, Holst DC, Komnos G, Koutalos A, Malizos K, Martinez Pastor JC, McPherson E, Meermans G, Mooney JA, Mortazavi J, Parsa A, Pecora JR, Pereira GA, Martos MS, Shohat N, Shope AJ, Zullo SS (2019) Hip and knee section, diagnosis, definitions: proceedings of international consensus on orthopedic infections. J Arthroplasty 34(2s):S329–s337
Ghosh S, Charity RM, Haidar SG, Singh BK (2006) Pyrexia following total knee replacement. Knee 13(4):324–327
Zajonz D, Wuthe L, Tiepolt S, Brandmeier P, Prietzel T, von Salis-Soglio GF, Roth A, Josten C, Heyde CE, Ghanem M (2015) Diagnostic work-up strategy for periprosthetic joint infections after total hip and knee arthroplasty: a 12-year experience on 320 consecutive cases. Patient Saf Surg 9:20
Tigges S, Stiles RG, Roberson JR (1994) Appearance of septic hip prostheses on plain radiographs. AJR Am J Roentgenol 163(2):377–380
Verberne SJ, Sonnega RJ, Temmerman OP, Raijmakers PG (2017) What is the accuracy of nuclear imaging in the assessment of periprosthetic knee infection? A meta-analysis. Clin Orthop Relat Res 475(5):1395–1410
Sofka CM (2007) Current applications of advanced cross-sectional imaging techniques in evaluating the painful arthroplasty. Skelet Radiol 36(3):183–193
Della Valle C, Parvizi J, Bauer TW, Dicesare PE, Evans RP, Segreti J, Spangehl M, Watters WC 3rd, Keith M, Turkelson CM, Wies JL, Sluka P, Hitchcock K (2010) Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg 18(12):760–770
Spangehl MJ, Masri BA, O'Connell JX, Duncan CP (1999) Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 81(5):672–683
Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 92(11):2102–2109
Larsson S, Thelander U, Friberg S (1992) C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop Relat Res (275):237-42
Nazem K, Motififard M, Yousefian M (2016) Variations in ESR and CRP in total knee arthroplasty and total hip arthroplasty in Iranian patients from 2009 to 2011. Adv Biomed Res 5:148
Shahi A, Kheir MM, Tarabichi M, Hosseinzadeh HRS, Tan TL, Parvizi J (2017) Serum D-Dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation. J Bone Joint Surg Am 99(17):1419–1427
Stone WZ, Gray CF, Parvataneni HK, Prieto HA (2019) Clinical evaluation of alpha defensin test following staged treatment of prosthetic joint infections. J Arthroplast 34:1446
Carli AV, Abdelbary H, Ahmadzai N, Cheng W, Shea B, Hutton B, Sniderman J, Philip Sanders BS, Esmaeilisaraji L, Skidmore B, Gauthier-Kwan OY, Bunting AC, Gauthier P, Crnic A, Logishetty K, Moher D, Fergusson D, Beaule PE (2019) Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review. J Bone Joint Surg Am 101(7):635–649
Lee YS, Koo KH, Kim HJ, Tian S, Kim TY, Maltenfort MG, Chen AF (2017) Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 99(24):2077–2084
Yoon HK, Cho SH, Lee DY, Kang BH, Lee SH, Moon DG, Kim DH, Nam DC, Hwang SC (2017) A review of the literature on culture-negative periprosthetic joint infection: epidemiology, diagnosis and treatment. Knee Surg Relat Res 29(3):155–164
Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345
Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR (2007) Culture-negative prosthetic joint infection. Clin Infect Dis 45(9):1113–1119
Phelan DM, Osmon DR, Keating MR, Hanssen AD (2002) Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 34(7):930–938
Bosshard PP (2011) Incubation of fungal cultures: how long is long enough? Mycoses 54(5):e539–e545
Tarabichi M, Shohat N, Goswami K, Alvand A, Silibovsky R, Belden K, Parvizi J (2018) Diagnosis of periprosthetic joint infection: the potential of next-generation sequencing. J Bone Joint Surg Am 100(2):147–154
Ivy MI, Thoendel MJ, Jeraldo PR, Greenwood-Quaintance KE, Hanssen AD, Abdel MP, Chia N, Yao JZ, Tande AJ, Mandrekar JN, Patel R (2018) Direct detection and identification of prosthetic joint infection pathogens in synovial fluid by metagenomic shotgun sequencing. J Clin Microbiol 56(9)
Shohat N, Bauer T, Buttaro M, Budhiparama N, Cashman J, Della Valle CJ, Drago L, Gehrke T, Marcelino Gomes LS, Goswami K, Hailer NP, Han SB, Higuera CA, Inaba Y, Jenny JY, Kjaersgaard-Andersen P, Lee M, Llinas A, Malizos K, Mont MA, Jones RM, Parvizi J, Peel T, Rivero-Boschert S, Segreti J, Soriano A, Sousa R, Spangehl M, Tan TL, Tikhilov R, Tuncay I, Winkler H, Witso E, Wouthuyzen-Bakker M, Young S, Zhang X, Zhou Y, Zimmerli W (2019) Hip and knee section, what is the definition of a periprosthetic joint infection (PJI) of the knee and the hip? Can the same criteria be used for both joints? Proceedings of International Consensus on Orthopedic Infections. J Arthroplast 34(2s):S325–s327
Cochran AR, Ong KL, Lau E, Mont MA, Malkani AL (2016) Risk of reinfection after treatment of infected total knee arthroplasty. J Arthroplast 31(9 Suppl):156–161
Goulet JA, Pellicci PM, Brause BD, Salvati EM (1988) Prolonged suppression of infection in total hip arthroplasty. J Arthroplast 3(2):109–116
Rao N, Crossett LS, Sinha RK, Le Frock JL (2003) Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res 414:55–60
Siqueira MB, Saleh A, Klika AK, O'Rourke C, Schmitt S, Higuera CA, Barsoum WK (2015) Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship. J Bone Joint Surg Am 97(15):1220–1232
Haasper C, Buttaro M, Hozack W, Aboltins CA, Borens O, Callaghan JJ, de Carvalho PI, Chang Y, Corona P, Da Rin F, Esposito S, Fehring TK, Sanchez XF, Lee GC, Martinez-Pastor JC, Mortazavi SM, Noiseux NO, Peng KT, Schutte HD, Schweitzer D, Trebse R, Tsiridis E, Whiteside L (2014) Irrigation and debridement. J Arthroplast 29(2 Suppl):100–103
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, Taylor A, Palomares EB, Murillo O, Parvizi J, Shohat N, Reinoso JC, Sanchez RE, Fernandez-Sampedro M, Senneville E, Huotari K, Barbero JM, Garcia-Canete J, Lora-Tamayo J, Ferrari MC, Vaznaisiene D, Yusuf E, Aboltins C, Trebse R, Salles MJ, Benito N, Vila A, Toro MDD, Kramer TS, Petersdorf S, Diaz-Brito V, Tufan ZK, Sanchez M, Arvieux C, Soriano A (2019) Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention. J Infect 78(1):40–47
Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J (2011) Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res 469(11):3043–3048
Fehring TK, Odum SM, Berend KR, Jiranek WA, Parvizi J, Bozic KJ, Della Valle CJ, Gioe TJ (2013) Failure of irrigation and debridement for early postoperative periprosthetic infection. Clin Orthop Relat Res 471(1):250–257
Odum SM, Fehring TK, Lombardi AV, Zmistowski BM, Brown NM, Luna JT, Fehring KA, Hansen EN (2011) Irrigation and debridement for periprosthetic infections: does the organism matter? J Arthroplast 26(6 Suppl):114–118
Tsang SJ, Ting J, Simpson A, Gaston P (2017) Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies. Bone Joint J 99-b(11):1458–1466
Volpin A, Sukeik M, Alazzawi S, Haddad FS (2016) Aggressive early debridement in treatment of acute periprosthetic joint infections after hip and knee replacements. Open Orthop J 10:669–678
Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A (1981) Management of deep infection of total hip replacement. J Bone Joint Surg Br 63-b(3):342–353
Jackson WO, Schmalzried TP (2000) Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 381:101–105
Lange J, Troelsen A, Solgaard S, Otte KS, Jensen NK, Soballe K (2018) Cementless one-stage revision in chronic periprosthetic hip joint infection. Ninety-one percent infection free survival in 56 patients at minimum 2-year follow-up. J Arthroplast 33(4):1160–1165.e1
Bori G, Navarro G, Morata L, Fernandez-Valencia JA, Soriano A, Gallart X (2018) Preliminary results after changing from two-stage to one-stage revision arthroplasty protocol using cementless arthroplasty for chronic infected hip replacements. J Arthroplast 33(2):527–532
Wolf M, Clar H, Friesenbichler J, Schwantzer G, Bernhardt G, Gruber G, Glehr M, Leithner A, Sadoghi P (2014) Prosthetic joint infection following total hip replacement: results of one-stage versus two-stage exchange. Int Orthop 38(7):1363–1368
Jenny JY, Lengert R, Diesinger Y, Gaudias J, Boeri C, Kempf JF (2014) Routine one-stage exchange for chronic infection after total hip replacement. Int Orthop 38(12):2477–2481
Raut VV, Siney PD, Wroblewski BM (1994) One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 76(5):721–724
Leonard HA, Liddle AD, Burke O, Murray DW, Pandit H (2014) Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature. Clin Orthop Relat Res 472(3):1036–1042
George DA, Logoluso N, Castellini G, Gianola S, Scarponi S, Haddad FS, Drago L, Romano CL (2016) Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review. BMC Infect Dis 16(1):553
Haddad FS, Sukeik M, Alazzawi S (2015) Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res 473(1):8–14
Romano CL, Gala L, Logoluso N, Romano D, Drago L (2012) Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers. Knee Surg Sports Traumatol Arthrosc 20(12):2445–2453
Vaishya R, Chauhan M, Vaish A (2013) Bone cement. J Clin Orthop Trauma 4(4):157–163
Carli AV, Sethuraman AS, Bhimani SJ, Ross FP, Bostrom MPG (2018) Selected heat-sensitive antibiotics are not inactivated during polymethylmethacrylate curing and can be used in cement spacers for periprosthetic joint infection. J Arthroplast 33(6):1930–1935
Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P (2017) Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res 6(5):296–306
Young SW, Zhang M, Freeman JT, Mutu-Grigg J, Pavlou P, Moore GA (2014) The Mark Coventry Award: higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial. Clin Orthop Relat Res 472(1):57–65
Roy ME, Peppers MP, Whiteside LA, Lazear RM (2014) Vancomycin concentration in synovial fluid: direct injection into the knee vs. intravenous infusion. J Arthroplast 29(3):564–568
Toulson C, Walcott-Sapp S, Hur J, Salvati E, Bostrom M, Brause B, Westrich GH (2009) Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol: update on “our institution’s” experience from 1989 to 2003. J Arthroplasty 24(7):1051–1060
Browne JA, Cancienne JM, Novicoff WM, Werner BC (2017) Removal of an infected hip arthroplasty is a high-risk surgery: putting morbidity into context with other major nonorthopedic operations. J Arthroplast 32(9):2834–2841
Lum ZC, Natsuhara KM, Shelton TJ, Giordani M, Pereira GC, Meehan JP (2018) Mortality during total knee periprosthetic joint infection. J Arthroplast 33(12):3783–3788
Conway JD, Mont MA, Bezwada HP (2004) Arthrodesis of the knee. J Bone Joint Surg Am 86-a(4):835–848
Waters RL, Perry J, Antonelli D, Hislop H (1976) Energy cost of walking of amputees: the influence of level of amputation. J Bone Joint Surg Am 58(1):42–46
Balato G, Rizzo M, Ascione T, Smeraglia F, Mariconda M (2018) Re-infection rates and clinical outcomes following arthrodesis with intramedullary nail and external fixator for infected knee prosthesis: a systematic review and meta-analysis. BMC Musculoskelet Disord 19(1):361
Chen AF, Kinback NC, Heyl AE, McClain EJ, Klatt BA (2012) Better function for fusions versus above-the-knee amputations for recurrent periprosthetic knee infection. Clin Orthop Relat Res 470(10):2737–2745
Wu CH, Gray CF, Lee GC (2014) Arthrodesis should be strongly considered after failed two-stage reimplantation TKA. Clin Orthop Relat Res 472(11):3295–3304
Son MS, Lau E, Parvizi J, Mont MA, Bozic KJ, Kurtz S (2017) What are the frequency, associated factors, and mortality of amputation and arthrodesis after a failed infected TKA? Clin Orthop Relat Res 475(12):2905–2913
Carr JB 2nd, Werner BC, Browne JA (2016) Trends and outcomes in the treatment of failed septic total knee arthroplasty: comparing arthrodesis and above-knee amputation. J Arthroplast 31(7):1574–1577
Khanna V, Tushinski DM, Soever LJ, Vincent AD, Backstein DJ (2015) Above knee amputation following total knee arthroplasty: when enough is enough. J Arthroplast 30(4):658–662
Castellanos J, Flores X, Llusa M, Chiriboga C, Navarro A (1998) The Girdlestone pseudarthrosis in the treatment of infected hip replacements. Int Orthop 22(3):178–181
Cordero-Ampuero J (2012) Girdlestone procedure: when and why. Hip Int 22(Suppl 8):S36–S39
Zalavras CG, Rigopoulos N, Ahlmann E, Patzakis MJ (2009) Hip disarticulation for severe lower extremity infections. Clin Orthop Relat Res 467(7):1721–1726
Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D (2007) Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 89(6):1227–1231
McKenna PB, O'Shea K, Masterson EL (2009) Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch Orthop Trauma Surg 129(4):489–494
Hsieh PH, Huang KC, Lee PC, Lee MS (2009) Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemother 64(2):392–397
Bernard L, Legout L, Zurcher-Pfund L, Stern R, Rohner P, Peter R, Assal M, Lew D, Hoffmeyer P, Uckay I (2010) Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect 61(2):125–132
Bassetti M, Cadeo B, Villa G, Sartor A, Cainero V, Causero A (2014) Current antibiotic management of prosthetic joint infections in Italy: the ‘Udine strategy’. J Antimicrob Chemother 69(Suppl 1):i41–i45
Darley ES, Bannister GC, Blom AW, Macgowan AP, Jacobson SK, Alfouzan W (2011) Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement. J Antimicrob Chemother 66(10):2405–2408
Farhad R, Roger PM, Albert C, Pelligri C, Touati C, Dellamonica P, Trojani C, Boileau P (2010) Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis 29(2):217–222
Redfern RE, Cameron-Ruetz C, O'Drobinak SK, Chen JT, Beer KJ (2017) Closed incision negative pressure therapy effects on postoperative infection and surgical site complication after total hip and knee arthroplasty. J Arthroplast 32(11):3333–3339
Karlakki SL, Hamad AK, Whittall C, Graham NM, Banerjee RD, Kuiper JH (2016) Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: a randomised controlled trial. Bone Joint Res 5(8):328–337
Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89(1):33–38
Cizmic Z, Feng JE, Huang R, Iorio R, Komnos G, Kunutsor SK, Metwaly RG, Saleh UH, Sheth N, Sloan M (2019) Hip and knee section, prevention, host related: proceedings of international consensus on orthopedic infections. J Arthroplasty 34(2s):S255–s270
Acknowledgements
The authors would like to thank Suzanne Danley for her assistance and critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vaida, J., Dietz, M.J. (2020). When the Race Is Lost: The Clinical Impact of Prosthetic Joint Infections. In: Li, B., Moriarty, T., Webster, T., Xing, M. (eds) Racing for the Surface. Springer, Cham. https://doi.org/10.1007/978-3-030-34475-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-34475-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34474-0
Online ISBN: 978-3-030-34475-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)